State Street’s Syneron Medical Ltd ELOS Stock Holding History

State Street’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-73,425	Closed	-$803K	–	3811
2017 Q2	$803K	Hold	73,425	–	–	﹤0.01%	3368
2017 Q1	$775K	Buy	73,425 +1,834	+3%	+$17.7K	﹤0.01%	3324
2016 Q4	$602K	Buy	71,591 +25,553	+56%	+$200K	﹤0.01%	3372
2016 Q3	$329K	Hold	46,038	–	–	﹤0.01%	3350
2016 Q2	$354K	Buy	46,038 +24,337	+112%	+$173K	﹤0.01%	3444
2016 Q1	$158K	Hold	21,701	–	–	﹤0.01%	3512
2015 Q4	$167K	Hold	21,701	–	–	﹤0.01%	3504
2015 Q3	$155K	Hold	21,701	–	–	﹤0.01%	3494
2015 Q2	$231K	Buy	21,701 +10,039	+86%	+$118K	﹤0.01%	3469
2015 Q1	$145K	Hold	11,662	–	–	﹤0.01%	3518
2014 Q4	$109K	Hold	11,662	–	–	﹤0.01%	3541
2014 Q3	$117K	Sell	11,662 -4,636	-28%	-$47.2K	﹤0.01%	3506
2014 Q2	$168K	Buy	16,298 +228	+1%	+$2.46K	﹤0.01%	3442
2014 Q1	$201K	Buy	+16,070	New	+$190K	﹤0.01%	3467

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

State Street's ELOS Position: Q3 2017 in Review

State Street sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 73,425 shares — an estimated $803K sold.

State Street first reported a position in ELOS in Q1 2014 and held it in 14 quarters. The position peaked at $803K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

State Street reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
State Street sold 73,425 Syneron Medical Ltd shares in Q3 2017, an estimated $803K.
State Street first reported a position in Syneron Medical Ltd in Q1 2014 and held it in 14 quarters.
State Street's Syneron Medical Ltd position peaked at $803K in Q2 2017.
4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on State Street's 13F filing for Q3 2017, filed 14 Nov 2017.